A citation-based method for searching scientific literature

Nalinda B Wasala, Shi-Jie Chen, Dongsheng Duan. Expert Opin Drug Discov 2020
Times Cited: 8







List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.
Yi-Li Min, Hui Li, Cristina Rodriguez-Caycedo, Alex A Mireault, Jian Huang, John M Shelton, John R McAnally, Leonela Amoasii, Pradeep P A Mammen, Rhonda Bassel-Duby,[...]. Sci Adv 2019
78
62

Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.
A Moretti, L Fonteyne, F Giesert, P Hoppmann, A B Meier, T Bozoglu, A Baehr, C M Schneider, D Sinnecker, K Klett,[...]. Nat Med 2020
43
62

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
Catherine L Bladen, David Salgado, Soledad Monges, Maria E Foncuberta, Kyriaki Kekou, Konstantina Kosma, Hugh Dawkins, Leanne Lamont, Anna J Roy, Teodora Chamova,[...]. Hum Mutat 2015
277
50

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
630
50

Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.
Chengzu Long, Leonela Amoasii, Alex A Mireault, John R McAnally, Hui Li, Efrain Sanchez-Ortiz, Samadrita Bhattacharyya, John M Shelton, Rhonda Bassel-Duby, Eric N Olson. Science 2016
540
50

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.
Joe W McGreevy, Chady H Hakim, Mark A McIntosh, Dongsheng Duan. Dis Model Mech 2015
217
50

Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.
Christopher E Nelson, Yaoying Wu, Matthew P Gemberling, Matthew L Oliver, Matthew A Waller, Joel D Bohning, Jacqueline N Robinson-Hamm, Karen Bulaklak, Ruth M Castellanos Rivera, Joel H Collier,[...]. Nat Med 2019
126
50

Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.
Leonela Amoasii, Chengzu Long, Hui Li, Alex A Mireault, John M Shelton, Efrain Sanchez-Ortiz, John R McAnally, Samadrita Bhattacharyya, Florian Schmidt, Dirk Grimm,[...]. Sci Transl Med 2017
97
50

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
Niclas E Bengtsson, John K Hall, Guy L Odom, Michael P Phelps, Colin R Andrus, R David Hawkins, Stephen D Hauschka, Joel R Chamberlain, Jeffrey S Chamberlain. Nat Commun 2017
186
50

Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.
Yu Zhang, Hui Li, Yi-Li Min, Efrain Sanchez-Ortiz, Jian Huang, Alex A Mireault, John M Shelton, Jiwoong Kim, Pradeep P A Mammen, Rhonda Bassel-Duby,[...]. Sci Adv 2020
37
50


Functional correction of dystrophin actin binding domain mutations by genome editing.
Viktoriia Kyrychenko, Sergii Kyrychenko, Malte Tiburcy, John M Shelton, Chengzu Long, Jay W Schneider, Wolfram-Hubertus Zimmermann, Rhonda Bassel-Duby, Eric N Olson. JCI Insight 2017
43
37

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges.
Yusuke Echigoya, Kenji Rowel Q Lim, Akinori Nakamura, Toshifumi Yokota. J Pers Med 2018
25
37

Identification of preexisting adaptive immunity to Cas9 proteins in humans.
Carsten T Charlesworth, Priyanka S Deshpande, Daniel P Dever, Joab Camarena, Viktor T Lemgart, M Kyle Cromer, Christopher A Vakulskas, Michael A Collingwood, Liyang Zhang, Nicole M Bode,[...]. Nat Med 2019
257
37

AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice.
Chady H Hakim, Nalinda B Wasala, Christopher E Nelson, Lakmini P Wasala, Yongping Yue, Jacqueline A Louderman, Thais B Lessa, Aihua Dai, Keqing Zhang, Gregory J Jenkins,[...]. JCI Insight 2018
38
37

Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy.
Seuk-Min Ryu, Taeyoung Koo, Kyoungmi Kim, Kayeong Lim, Gayoung Baek, Sang-Tae Kim, Heon Seok Kim, Da-Eun Kim, Hyunji Lee, Eugene Chung,[...]. Nat Biotechnol 2018
167
37

Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
Leonela Amoasii, John C W Hildyard, Hui Li, Efrain Sanchez-Ortiz, Alex Mireault, Daniel Caballero, Rachel Harron, Thaleia-Rengina Stathopoulou, Claire Massey, John M Shelton,[...]. Science 2018
201
37

Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing.
Chengzu Long, Hui Li, Malte Tiburcy, Cristina Rodriguez-Caycedo, Viktoriia Kyrychenko, Huanyu Zhou, Yu Zhang, Yi-Li Min, John M Shelton, Pradeep P A Mammen,[...]. Sci Adv 2018
108
37

Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
Courtney S Young, Ekaterina Mokhonova, Marbella Quinonez, April D Pyle, Melissa J Spencer. J Neuromuscul Dis 2017
39
37

Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
David G Ousterout, Ami M Kabadi, Pratiksha I Thakore, William H Majoros, Timothy E Reddy, Charles A Gersbach. Nat Commun 2015
251
37

AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.
Michael E Nance, Ruicheng Shi, Chady H Hakim, Nalinda B Wasala, Yongping Yue, Xiufang Pan, Tracy Zhang, Carolyn A Robinson, Sean X Duan, Gang Yao,[...]. Mol Ther 2019
20
37

Eteplirsen in the treatment of Duchenne muscular dystrophy.
Kenji Rowel Q Lim, Rika Maruyama, Toshifumi Yokota. Drug Des Devel Ther 2017
171
37

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair.
Kunwoo Lee, Michael Conboy, Hyo Min Park, Fuguo Jiang, Hyun Jin Kim, Mark A Dewitt, Vanessa A Mackley, Kevin Chang, Anirudh Rao, Colin Skinner,[...]. Nat Biomed Eng 2017
277
37

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.
Chengzu Long, John R McAnally, John M Shelton, Alex A Mireault, Rhonda Bassel-Duby, Eric N Olson. Science 2014
386
37

In vivo gene editing in dystrophic mouse muscle and muscle stem cells.
Mohammadsharif Tabebordbar, Kexian Zhu, Jason K W Cheng, Wei Leong Chew, Jeffrey J Widrick, Winston X Yan, Claire Maesner, Elizabeth Y Wu, Ru Xiao, F Ann Ran,[...]. Science 2016
579
37

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
37

Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
Vedell Louis Jeune, Jakob A Joergensen, Roger J Hajjar, Thomas Weber. Hum Gene Ther Methods 2013
133
25

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Sylvie Boutin, Virginie Monteilhet, Philippe Veron, Christian Leborgne, Olivier Benveniste, Marie Françoise Montus, Carole Masurier. Hum Gene Ther 2010
477
25

In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse.
Leonela Amoasii, Hui Li, Yu Zhang, Yi-Li Min, Efrain Sanchez-Ortiz, John M Shelton, Chengzu Long, Alex A Mireault, Samadrita Bhattacharyya, John R McAnally,[...]. Nat Commun 2019
13
25

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.
Janice S Chen, Yavuz S Dagdas, Benjamin P Kleinstiver, Moira M Welch, Alexander A Sousa, Lucas B Harrington, Samuel H Sternberg, J Keith Joung, Ahmet Yildiz, Jennifer A Doudna. Nature 2017
453
25

High levels of AAV vector integration into CRISPR-induced DNA breaks.
Killian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, Mikołaj P Zaborowski, Adrienn Volak, Stefan E Spirig, Alissa Muller, Alexander A Sousa, Shengdar Q Tsai, Niclas E Bengtsson,[...]. Nat Commun 2019
77
25

Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
Hongmei Lisa Li, Naoko Fujimoto, Noriko Sasakawa, Saya Shirai, Tokiko Ohkame, Tetsushi Sakuma, Michihiro Tanaka, Naoki Amano, Akira Watanabe, Hidetoshi Sakurai,[...]. Stem Cell Reports 2015
308
25

In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
Mona El Refaey, Li Xu, Yandi Gao, Benjamin D Canan, T M Ayodele Adesanya, Sarah C Warner, Keiko Akagi, David E Symer, Peter J Mohler, Jianjie Ma,[...]. Circ Res 2017
71
25

Improved diagnosis of Becker muscular dystrophy by dystrophin testing.
E P Hoffman, L M Kunkel, C Angelini, A Clarke, M Johnson, J B Harris. Neurology 1989
227
25


Clinical development on the frontier: gene therapy for duchenne muscular dystrophy.
Damon R Asher, Khampaseuth Thapa, Sachi D Dharia, Navid Khan, Rachael A Potter, Louise R Rodino-Klapac, Jerry R Mendell. Expert Opin Biol Ther 2020
17
25

Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy.
Ana M Moreno, Nathan Palmer, Fernando Alemán, Genghao Chen, Andrew Pla, Ning Jiang, Wei Leong Chew, Mansun Law, Prashant Mali. Nat Biomed Eng 2019
28
25

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Benjamin P Kleinstiver, Vikram Pattanayak, Michelle S Prew, Shengdar Q Tsai, Nhu T Nguyen, Zongli Zheng, J Keith Joung. Nature 2016
25

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
A P Monaco, C J Bertelson, S Liechti-Gallati, H Moser, L M Kunkel. Genomics 1988
901
25

CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.
Yu Zhang, Chengzu Long, Hui Li, John R McAnally, Kedryn K Baskin, John M Shelton, Rhonda Bassel-Duby, Eric N Olson. Sci Adv 2017
121
25

The 2020 version of the gene table of neuromuscular disorders (nuclear genome).
Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun. Neuromuscul Disord 2019
31
25

CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice.
Li Xu, Ki Ho Park, Lixia Zhao, Jing Xu, Mona El Refaey, Yandi Gao, Hua Zhu, Jianjie Ma, Renzhi Han. Mol Ther 2016
139
25


Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.
Carmela Zincarelli, Stephen Soltys, Giuseppe Rengo, Joseph E Rabinowitz. Mol Ther 2008
748
25

Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells.
Andrea Lh Arnett, Patryk Konieczny, Julian N Ramos, John Hall, Guy Odom, Zipora Yablonka-Reuveni, Joel R Chamberlain, Jeffrey S Chamberlain. Mol Ther Methods Clin Dev 2014
51
25

CRISPR RNAs trigger innate immune responses in human cells.
Sojung Kim, Taeyoung Koo, Hyeon-Gun Jee, Hee-Yeon Cho, Gyeorae Lee, Dong-Gyun Lim, Hyoung Shik Shin, Jin-Soo Kim. Genome Res 2018
92
25

Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.
Shayesteh R Ferdosi, Radwa Ewaisha, Farzaneh Moghadam, Sri Krishna, Jin G Park, Mo R Ebrahimkhani, Samira Kiani, Karen S Anderson. Nat Commun 2019
51
25

Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing.
Yu Zhang, Chengzu Long, Rhonda Bassel-Duby, Eric N Olson. Physiol Rev 2018
12
25

Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
Yafeng Song, Leon Morales, Alock S Malik, Andrew F Mead, Christopher D Greer, Marilyn A Mitchell, Mihail T Petrov, Leonard T Su, Margaret E Choi, Shira T Rosenblum,[...]. Nat Med 2019
31
25

Animal models are essential to biological research: issues and perspectives.
Françoise Barré-Sinoussi, Xavier Montagutelli. Future Sci OA 2015
82
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.